Novo Nordisk A/S ADR (NVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2004 | 03-2004 | 12-2003 | 09-2003 | 06-2003 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 386,000 | 177,000 | 740,350 | N/A | N/A |
| Depreciation Amortization | 0 | 0 | 246,730 | N/A | N/A |
| Other Working Capital | -59,000 | 28,000 | -192,930 | N/A | N/A |
| Other Operating Activity | 172,000 | 17,000 | 144,480 | 0 | 0 |
| Operating Cash Flow | $499,000 | $222,000 | $938,630 | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -169,000 | -65,000 | -352,340 | N/A | N/A |
| Net Acquisitions | 0 | 0 | 1,520 | N/A | N/A |
| Other Investing Activity | 183,000 | 154,000 | -1,680 | 0 | 0 |
| Investing Cash Flow | $14,000 | $89,000 | $-352,500 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Dividend Paid | 0 | 0 | -189,430 | N/A | N/A |
| Other Financing Activity | -360,000 | -248,000 | -175,410 | 0 | 0 |
| Financing Cash Flow | $-360,000 | $-248,000 | $-364,840 | $N/A | $N/A |
| Exchange Rate Effect | -2,000 | 1,000 | -2,590 | N/A | N/A |
| Beginning Cash Position | 137,000 | 138,000 | 188,060 | N/A | N/A |
| End Cash Position | 288,000 | 202,000 | 406,750 | N/A | N/A |
| Net Cash Flow | $151,000 | $64,000 | $218,690 | $N/A | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | 499,000 | 222,000 | 938,630 | N/A | N/A |
| Free Cash Flow | 499,000 | 222,000 | 938,630 | 0 | 0 |